Pentoxifylline therapy for hepatopulmonary syndrome: A pilot study

Archives of Internal Medicine

Volumn 168, Issue 16, 2008, Pages 1820-1823

  Gupta, Lal Babu ^b   Kumar, Ashish ^b   Jaiswal, Ashish Kumar ^b   Yusuf, Jamal ^b   Mehta, Vimal ^b   Tyagi, Sanjay ^b   Tempe, Deepak K ^b   Sharma, Barjesh Chander ^b   Sarin, Shiv Kumar ^a  

^a G B PANT HOSPITAL   (India)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

PENTOXIFYLLINE;

ADULT; CLINICAL TRIAL; CONTRAST ENHANCEMENT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG MECHANISM; ECHOCARDIOGRAPHY; FEMALE; GASTROINTESTINAL ENDOSCOPE; HEPATOPULMONARY SYNDROME; HUMAN; LETTER; LIVER CIRRHOSIS; LIVER FUNCTION TEST; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; OXYGEN TENSION; PATIENT MONITORING; PRIORITY JOURNAL; SIDE EFFECT; THORAX RADIOGRAPHY; TREATMENT RESPONSE; VOMITING;

ADOLESCENT; ADULT; ANIMALS; BLOOD GAS ANALYSIS; FEMALE; HEPATOPULMONARY SYNDROME; HUMANS; MALE; MIDDLE AGED; OXYGEN; PENTOXIFYLLINE; PHOSPHODIESTERASE INHIBITORS; PILOT PROJECTS; TREATMENT OUTCOME;

EID: 51649114024     PISSN: 00039926     EISSN: 15383679     Source Type: Journal    
DOI: 10.1001/archinte.168.16.1820     Document Type: Letter

References (20)

1. Rodríquez-Roisin R, Krowka MJ, Hervé P, Fallon MB; ERS (European Respiratory Society) Task Force-PHD Scientific Committee. Highlights of the ERS Task Force on pulmonary-hepatic vascular disorders (PHD). J Hepatol. 2005;42(6):924-927.
2. Gaines DI, Fallon MB. Hepatopulmonary syndrome. Liver Int. 2004;24(5):397-401.
3. Luo B, Liu L, Tang L, Zhang J, Ling Y, Fallon MB. ET-1 and TNF-alpha in HPS: analysis in prehepatic portal hypertension and biliary and nonbiliary cirrhosis in rats. Am J Physiol Gastrointest Liver Physiol. 2004;286(2):G294-G303.
4. Zhang HY, Han DW, Zhao ZF, et al. Multiple pathogenic factor-induced complications of cirrhosis in rats: a new model of hepatopulmonary syndrome with intestinal endotoxemia. World J Gastroenterol. 2007;13(25):3500-3507.
5. Panos RJ, Baker SK. Mediators, cytokines, and growth factors in liver-lung interactions. Clin Chest Med. 1996;17(1):151-169.
6. Zabel P, Schade FU, Schlaak M. Inhibition of endogenous TNF formation by pentoxifylline. Immunobiology. 1993;187(3-5):447-463.
7. Loftis LL, Meals EA, English BK. Differential effects of pentoxifylline and interleukin-10 on production of tumor necrosis factor and inducible nitric oxide synthase by murine macrophages. J Infect Dis. 1997;175(4):1008- 1011.
8. Beshay E, Croze F, Prud'homme GJ. The phosphodiesterase inhibitors pentoxifylline and rolipram suppress macrophage activation and nitric oxide production in vitro and in vivo. Clin Immunol. 2001;98(2):272-279.
9. Trajković V, Badovinac V, Popadic D, Hadzic O, Stojkovic MM. Cell-specific effects of pentoxifylline on nitric oxide production and inducible nitric oxide synthase mRNA expression. Immunology. 1997;92(3):402-406.
10. Poulakis N, Androutsos G, Kazi D, et al. The differential effect of pentoxifylline on cytokine production by alveolar macrophages and its clinical implications. Respir Med. 1999;93(1):52-57.
11. Sztrymf B, Rabiller A, Nunes H, et al. Prevention of hepatopulmonary syndrome and hyperdynamic state by pentoxifylline in cirrhotic rats. Eur Respir J. 2004;23(5):752-758.
12. Zhang J, Ling Y, Tang L, et al. Pentoxifylline attenuation of experimental hepatopulmonary syndrome. J Appl Physiol. 2007;102(3):949-955.
13. Najafi Sani M, Kianifar HR, Kianee A, Khatami G. Effect of oral garlic on arterial oxygen pressure in children with hepatopulmonary syndrome. World J Gastroenterol. 2006;12(15):2427-2431.
14. Lange PA, Stoller JK. The hepatopulmonary syndrome: effect of liver transplantation. Clin Chest Med. 1996;17(1):115-123.
15. Mews CF, Dorney SF, Sheil AG, Forbes DA, Hill RE. Failure of liver transplantation in Wilson's disease with pulmonary arteriovenous shunting. J Pediatr Gastroenterol Nutr. 1990;10(2):230-233.
16. Abrams GA, Fallon MB. Treatment of hepatopulmonary syndrome with Allium sativum L. (garlic): a pilot trial. J Clin Gastroenterol. 1998;27(3):232-235.
17. Song JY, Choi JY, Ko JT, et al. Long-term aspirin therapy for hepatopulmonary syndrome. Pediatrics. 1996;97(6, pt 1):917-920.
18. Schenk P, Madl C, Rezaie-Majd S, Lehr S, Muller C. Methylene blue improves the hepatopulmonary syndrome. Ann Intern Med. 2000;133(9):701-706.
19. Gómez FP, Barbera JA, Roca J, Burgos F, Gistau C, Rodriguez-Roisin R. Effects of nebulized N(G)-nitro-L-arginine methyl ester in patients with hepatopulmonary syndrome. Hepatology. 2006;43(5):1084-1091.
20. Miot-Noirault E, Faure L, Guichard Y, Montharu J, Le Pape A. Scintigraphic in vivo assessment of the development of pulmonary intravascular macrophages in liver disease: experimental study in rats with biliary cirrhosis. Chest. 2001;120(3):941-947.